Feinberg Peter

CIK 00018700762 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001870076

Recent Transactions

34 trades

Purchase
Immuneering Corp$IMRX
Class A Common Stock
2026-01-12$4.35/sh+20,000→ 135,441 total
Award
Immuneering Corp$IMRX
Stock Option
2026-01-01+7,888→ 7,888 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2025-10-03$6.67/sh+7,500→ 156,766 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2025-09-30$7.03/sh+7,500→ 149,266 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2025-09-29$7.18/sh+5,000→ 141,766 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2025-06-18$2.53/sh+25,000→ 136,766 total
Award
Immuneering Corp$IMRX
Stock Option
2025-06-13+33,350→ 33,350 total
Award
Immuneering Corp$IMRX
Stock Option
2025-01-01+23,485→ 23,485 total
Award
Immuneering Corp$IMRX
Stock Option
2024-06-12+33,350→ 33,350 total
Award
Notable Labs, Ltd.
Ordinary Shares
2024-05-08+40,247→ 40,247 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2024-03-22$2.55/sh+25,000→ 111,766 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2024-03-19$2.56/sh+25,000→ 86,766 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2024-03-18$3.05/sh+4,976→ 61,766 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2024-03-18$2.31/sh+45,024→ 56,790 total
Award
Notable Labs, Ltd.
Stock Option
2024-01-24+9,753→ 9,753 total
Award
Immuneering Corp$IMRX
Stock Option
2024-01-01+6,879→ 6,879 total
Award
Immuneering Corp$IMRX
Stock Option
2023-06-14+17,500→ 17,500 total
Award
Immuneering Corp$IMRX
Stock Option
2022-06-21+14,200→ 14,200 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2022-03-15$6.75/sh+6,667→ 11,766 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2021-09-20$24.45/sh+4,750→ 5,099 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2021-09-13$21.51/sh+5,750→ 392,242 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2021-09-13$21.25/sh+349→ 349 total
Conversion
Immuneering Corp$IMRX
Series B Preferred Stock
2021-08-03−30,646→ 0 total
Conversion
Immuneering Corp$IMRX
Series B Preferred Stock
2021-08-03−30,646→ 0 total
Conversion
Immuneering Corp$IMRX
Series A Preferred Stock
2021-08-03−102,926→ 0 total
Conversion
Immuneering Corp$IMRX
Class A Common Stock
2021-08-03+123,155→ 347,401 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2021-08-03$15.00/sh+129,167→ 386,492 total
Conversion
Immuneering Corp$IMRX
Class A Common Stock
2021-08-03+133,572→ 257,325 total
Conversion
Immuneering Corp$IMRX
Series A Preferred Stock
2021-08-03−51,462→ 0 total
Conversion
Immuneering Corp$IMRX
Series A Preferred Stock
2021-08-03−92,509→ 0 total
Conversion
Immuneering Corp$IMRX
Class A Common Stock
2021-08-03+82,108→ 82,108 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2021-08-03$15.00/sh+129,167→ 476,568 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2021-08-03$15.00/sh+33,333→ 115,441 total
Conversion
Immuneering Corp$IMRX
Series B Preferred Stock
2021-08-03−30,646→ 0 total

Feinberg Peter

Recent Transactions

Companies

Recent Filings

Address